UA115002U - METHOD OF DIAGNOSIS OF THE EXPRESSION OF ATEROSCLEROTIC IMPACT OF CORONARY VESSELS IN PATIENTS WITH TYPE 2 DIABETES - Google Patents

METHOD OF DIAGNOSIS OF THE EXPRESSION OF ATEROSCLEROTIC IMPACT OF CORONARY VESSELS IN PATIENTS WITH TYPE 2 DIABETES

Info

Publication number
UA115002U
UA115002U UAU201611252U UAU201611252U UA115002U UA 115002 U UA115002 U UA 115002U UA U201611252 U UAU201611252 U UA U201611252U UA U201611252 U UAU201611252 U UA U201611252U UA 115002 U UA115002 U UA 115002U
Authority
UA
Ukraine
Prior art keywords
diagnosis
patients
level
type
diabetes
Prior art date
Application number
UAU201611252U
Other languages
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to UAU201611252U priority Critical patent/UA115002U/en
Publication of UA115002U publication Critical patent/UA115002U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Спосіб діагностики атеросклеротичного ураження коронарних судин у хворих на цукровий діабет 2-го типу включає визначення рівня фракталкіну в сироватці крові. При реєстрації підвищення рівня фракталкіну у порівнянні до контрольних значень коронарний атеросклероз діагностують при його рівні >466 пг/мл. Гемодинамічно значущий стеноз діагностують при рівні фракталкіну >468 пг/мл. Дифузне ураження коронарної судини діагностують при рівні фракталкіну >596 пг/мл.A method for the diagnosis of atherosclerotic lesions of coronary vessels in patients with type 2 diabetes involves determining the level of fractalkin in serum. When registering an increase in the level of fractalkin compared to control values, coronary atherosclerosis is diagnosed at its level> 466 pg / ml. Hemodynamically significant stenosis is diagnosed at fractal level> 468 pg / ml. Diffuse coronary vessel lesions are diagnosed at fractal alkaline levels> 596 pg / ml.

UAU201611252U 2016-11-07 2016-11-07 METHOD OF DIAGNOSIS OF THE EXPRESSION OF ATEROSCLEROTIC IMPACT OF CORONARY VESSELS IN PATIENTS WITH TYPE 2 DIABETES UA115002U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201611252U UA115002U (en) 2016-11-07 2016-11-07 METHOD OF DIAGNOSIS OF THE EXPRESSION OF ATEROSCLEROTIC IMPACT OF CORONARY VESSELS IN PATIENTS WITH TYPE 2 DIABETES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201611252U UA115002U (en) 2016-11-07 2016-11-07 METHOD OF DIAGNOSIS OF THE EXPRESSION OF ATEROSCLEROTIC IMPACT OF CORONARY VESSELS IN PATIENTS WITH TYPE 2 DIABETES

Publications (1)

Publication Number Publication Date
UA115002U true UA115002U (en) 2017-03-27

Family

ID=58531308

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201611252U UA115002U (en) 2016-11-07 2016-11-07 METHOD OF DIAGNOSIS OF THE EXPRESSION OF ATEROSCLEROTIC IMPACT OF CORONARY VESSELS IN PATIENTS WITH TYPE 2 DIABETES

Country Status (1)

Country Link
UA (1) UA115002U (en)

Similar Documents

Publication Publication Date Title
Pawade et al. Computed tomography aortic valve calcium scoring in patients with aortic stenosis
Blacher et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease
EP4054056A3 (en) Addressing borderline foreign object detection results
Dzeshka et al. Stroke and Bleeding Risk in Atrial Fibrillation: Navigating the Alphabet Soup of Risk‐Score Acronyms (CHADS2, CHA2DS2‐VASc, R2CHADS2, HAS‐BLED, ATRIA, and More)
BR112018015698A2 (en) ? diagnostic and prognostic methods for cardiovascular disease and events?
BR112018070971A2 (en) Methods and kits for diagnosis and risk stratification of patients with ischemia
WO2014140933A8 (en) Method for the prognosis and treatment of cancer metastasis
WO2015176066A3 (en) Lpa-associated protein and rna expression
BR112012022685A2 (en) Method and apparatus for determining a construction measurement in a vessel carrying a fluid medium
WO2014184679A3 (en) Method for the prognosis and treatment of renal cell carcinoma metastasis
Knebel et al. Exercise-induced changes of left ventricular diastolic function in postmenopausal amateur marathon runners: assessment by echocardiography and cardiac biomarkers
Demelo-Rodriguez et al. Pulmonary embolism: a practical guide for the busy clinician
Biyik et al. Echocardiographic and clinical abnormalities in patients with psoriasis
Mendes et al. Exercise tolerance in rats with aortic stenosis and ventricular diastolic and/or systolic dysfunction
WO2009125303A3 (en) Method and apparatus for determining a probability of colorectal cancer in a subject
UA115002U (en) METHOD OF DIAGNOSIS OF THE EXPRESSION OF ATEROSCLEROTIC IMPACT OF CORONARY VESSELS IN PATIENTS WITH TYPE 2 DIABETES
Li et al. Relationship between percentage of mean arterial pressure at the ankle and mortality in participants with normal ankle-brachial index: an observational study
Mele et al. Evaluation of left ventricular systolic function during atrial fibrillation: Is it reliable?
Kamishima et al. Effect of concurrent elevation of serum creatinine and C-reactive protein values on the long-term outcome in patients with ST-elevation acute myocardial infarction
Faggiano et al. MAC in CKD and dialysis patients: Pathophysiological doubts and clinical implications
Pastushkova et al. Identification of proteins of cardiovascular system in healthy subjects’ urine during “dry” immersion
Kozan et al. OP-175 Ratio of Aortic Flow Acceleration Time to Deceleration Time: A Novel Echocardiographic Parameter for Reduced LVEF?
Kudashova CHRONIC HEART FAILURE: SOME ASPECTS OF TRAINING OF PATIENTS
UA92113U (en) Method for prediction of development of diabetes insular of 2 type in patients with hypertonic disease by activity of apeline
Berezin Aortic stenosis: predictive value of cardiac biomarkers in older patients